Study provides a more accurate tool to stratify patients with HER2-positive breast cancer


Patients with a type of breast cancer called HER2-positive are less likely to survive if their initial treatment fails to eradicate the tumor completely and they have high levels of immune cells called tumor-infiltrating lymphocytes in the residual disease.

Caregivers’ coping strategies affect their level of distress and quality of life

Previous article

New discovery increases understanding of the effects of narcolepsy on the brain

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News